Canada markets open in 3 hours 39 minutes
CureVac N.V. (5CV.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 11:35AM CEST. Market open.
| Previous Close | 3.0400 |
| Open | 3.0800 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 2.9800 - 3.1160 |
| 52 Week Range | 2.0560 - 9.6000 |
| Volume | |
| Avg. Volume | 30,240 |
| Market Cap | 676.058M |
| Beta (5Y Monthly) | 2.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2200 |
| Earnings Date | Aug 15, 2024 - Aug 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 72.97 |
Barrons.comGSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
ZacksModerna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.
ACCESSWIRECureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation to create leaner and more agile organization Prioritization of high-value opportunities in oncology and other selected ...
© 2024 Yahoo. All rights reserved.